10 articles for YJ Wang
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Design and discovery of 4-anilinoquinazoline-acylamino derivatives as EGFR and VEGFR-2 dual TK inhibitors.

China Pharmaceutical University
Design, synthesis, and biological evaluation of crenatoside analogues as novel influenza neuraminidase inhibitors.

Central South University
Design and synthesis of human ABCB1 (P-glycoprotein) inhibitors by peptide coupling of diverse chemical scaffolds on carboxyl and amino termini of (S)-valine-derived thiazole amino acid.

St. John'S University
Design, synthesis and bioevaluation of PI3Kα-selective inhibitors as potential colorectal cancer drugs.

Guizhou Medical University
A new class of bradykinin 1 receptor antagonists containing the piperidine acetic acid tetralin core.

Amgen
High-throughput screening of novel pyruvate dehydrogenase kinases inhibitors and biological evaluation of their in vitro and in vivo antiproliferative activity.

Jiangsu Normal University
3-aroylmethylene-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-ones as potent Nrf2/ARE inducers in human cancer cells and AOM-DSS treated mice.

China Pharmaceutical University
7β-Methyl substituent is a structural locus associated with activity cliff for nepenthone analogues.

Fudan University
Tying up tranylcypromine: Novel selective histone lysine specific demethylase 1 (LSD1) inhibitors.

East China Normal University
Identification of 3-substituted-6-(1-(1H-[1,2,3]triazolo[4,5-b]pyrazin-1-yl)ethyl)quinoline derivatives as highly potent and selective mesenchymal-epithelial transition factor (c-Met) inhibitors via metabolite profiling-based structural optimization.

Shanghai Pharmaceuticals Holding